Katsanis E - Search Results

1

Davies SM, Wagner JE, Defor T, Blazar BR, Katsanis E, Kersey JH, Orchard PJ, McGlave PB, Weisdorf DJ, Ramsay NK. Davies SM, et al. Among authors: katsanis e. Br J Haematol. 1997 Mar;96(4):749-56. doi: 10.1046/j.1365-2141.1997.d01-2087.x. Br J Haematol. 1997. PMID: 9074418 Free article.

2

Multiagent Intratumoral Immunotherapy Can Be Effective in A20 Lymphoma Clearance and Generation of Systemic T Cell Immunity.

Gilman KE, Matiatos AP, Cracchiolo MJ, Moon AG, Davini DW, Simpson RJ, Katsanis E. Gilman KE, et al. Among authors: katsanis e. Cancers (Basel). 2023 Mar 24;15(7):1951. doi: 10.3390/cancers15071951. Cancers (Basel). 2023. PMID: 37046612 Free PMC article.

3

Importance in timing of cyclophosphamide on the enhancement of interleukin-2-induced cytolysis.

Katsanis E, Bausero MA, Ochoa AC, Loeffler CM, Blazar BR, Leonard AS, Anderson PM. Katsanis E, et al. Cancer Immunol Immunother. 1991;34(2):74-8. doi: 10.1007/BF01741339. Cancer Immunol Immunother. 1991. PMID: 1760819 Free PMC article.

4

Proliferation and cytolytic function of anti-CD3 + interleukin-2 stimulated peripheral blood mononuclear cells following bone marrow transplantation.

Katsanis E, Anderson PM, Filipovich AH, Hasz DE, Rich ML, Loeffler CM, Ochoa AC, Weisdorf DJ. Katsanis E, et al. Blood. 1991 Sep 1;78(5):1286-91. Blood. 1991. PMID: 1831682 Free article.

5

Thyroid dysfunction following bone marrow transplantation: long-term follow-up of 80 pediatric patients.

Katsanis E, Shapiro RS, Robison LL, Haake RJ, Kim T, Pescovitz OH, Ramsay NK. Katsanis E, et al. Bone Marrow Transplant. 1990 May;5(5):335-40. Bone Marrow Transplant. 1990. PMID: 2350628 Clinical Trial.

6

Treatment of acquired severe aplastic anemia.

Katsanis E, Ramsay NK. Katsanis E, et al. Am J Pediatr Hematol Oncol. 1989 Fall;11(3):360-7. Am J Pediatr Hematol Oncol. 1989. PMID: 2675662 Review.

7

B7-1 expression decreases tumorigenicity and induces partial systemic immunity to murine neuroblastoma deficient in major histocompatibility complex and costimulatory molecules.

Katsanis E, Xu Z, Bausero MA, Dancisak BB, Gorden KB, Davis G, Gray GS, Orchard PJ, Blazar BR. Katsanis E, et al. Cancer Gene Ther. 1995 Mar;2(1):39-46. Cancer Gene Ther. 1995. PMID: 7542553

8

Short-term ex vivo activation of splenocytes with anti-CD3 plus IL-2 and infusion post-BMT into mice results in in vivo expansion of effector cells with potent anti-lymphoma activity.

Katsanis E, Xu Z, Anderson PM, Dancisak BB, Bausero MA, Weisdorf DJ, Blazar BR, Ochoa AC. Katsanis E, et al. Bone Marrow Transplant. 1994 Oct;14(4):563-72. Bone Marrow Transplant. 1994. PMID: 7858530

9

Transfection of the mouse ICAM-1 gene into murine neuroblastoma enhances susceptibility to lysis, reduces in vivo tumorigenicity and decreases ICAM-2-dependent killing.

Katsanis E, Bausero MA, Xu H, Orchard PJ, Xu Z, McIvor RS, Brian AA, Blazar BR. Katsanis E, et al. Cancer Immunol Immunother. 1994 Feb;38(2):135-41. doi: 10.1007/BF01526209. Cancer Immunol Immunother. 1994. PMID: 7905790 Free PMC article.

10

Interleukin-1 alpha administered after autologous transplantation: a phase I/II clinical trial.

Weisdorf D, Katsanis E, Verfaillie C, Ramsay NK, Haake R, Garrison L, Blazar BR. Weisdorf D, et al. Among authors: katsanis e. Blood. 1994 Sep 15;84(6):2044-9. Blood. 1994. PMID: 7915916 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

157 results

Search Page

Filters